United States · FDA National Drug Code directory
Bio Thalamus Phase
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43742-1625_74134059-2926-4fc6-bdcf-ced1474cbfbd
- Product NDC
- 43742-1625
- Form
- LIQUID
- Composition / generic term
- Adenosinum Cyclophosphoricum, Petroselinum sativum, Melatonin, Pineal Gland (Suis), Thalamus Opticus (Suis), L-Dopa, Viscum Album, Apiolum
- Labeler
- Deseret Biologicals, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20200309
- Source listing expiry
- 20261231
Source-listed ingredients
- ADENOSINE CYCLIC PHOSPHATE — 6 [hp_X]/mL
- PETROSELINUM CRISPUM WHOLE — 6 [hp_X]/mL
- MELATONIN — 6 [hp_X]/mL
- SUS SCROFA PINEAL GLAND — 8 [hp_X]/mL
- SUS SCROFA THALAMUS LATERAL GENICULATE NUCLEUS — 8 [hp_X]/mL
- LEVODOPA — 8 [hp_X]/mL
- VISCUM ALBUM FRUITING TOP — 10 [hp_X]/mL
- APIOLE (PARSLEY) — 15 [hp_C]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, DROPPER (43742-1625-1) · 43742-1625-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →